SCHEMBL30962817

SCHEMBL30962817

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(C)ccc(O[Si](C)(C)C(C)(C)C)c1C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 6/20 0.43
▸ JAK3 P52333 2/20 0.43
▸ KDR P35968 2/20 0.43
▸ MAPK14 Q16539 2/20 0.43
▸ TEK Q02763 1/20 0.43
▸ SIK1 P57059 2/20 0.43
▸ SIK2 Q9H0K1 2/20 0.43
▸ SIK3 Q9Y2K2 2/20 0.43
▸ WEE1 P30291 1/20 0.40
▸ TNK2 Q07912 2/20 0.39
▸ TTK P33981 1/20 0.39
▸ BTK Q06187 1/20 0.39
▸ JAK2 O60674 3/20 0.38
▸ EHMT2 Q96KQ7 1/20 0.38
▸ ALK Q9UM73 1/20 0.38
▸ TBK1 Q9UHD2 2/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ SRC P12931 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962908 0.94 WEE1 (0.43) LCKJAK3KDRMAPK14TEK
SCHEMBL30962922 0.90 WEE1 (0.44) LCKJAK3KDRMAPK14TEK
SCHEMBL30962897 0.87 SIK1 (0.47) LCKJAK3KDRMAPK14TEK
SCHEMBL30962719 0.86 PTK2 (0.40) LCKJAK3KDRMAPK14TEK
SCHEMBL30962750 0.84 TTK (0.40) LCKJAK3KDRMAPK14TEK
SCHEMBL27313548 0.84 SIK1 (0.50) LCKJAK3KDRMAPK14TEK
SCHEMBL30962865 0.84 SIK1 (0.50) LCKJAK3KDRMAPK14TEK
SCHEMBL30962850 0.84 SIK1 (0.48) LCKJAK3KDRMAPK14TEK
SCHEMBL30962941 0.84 LCK (0.44) LCKJAK3KDRMAPK14TEK
SCHEMBL30962699 0.82 SRC (0.53) LCKJAK3KDRMAPK14TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback